Atlas Trials

Pralatrexate for Relapsed or Refractory Peripheral T-cell Lymphoma

Clinical trial NCT03356678 · COMPLETED

Trial details

NCT number
NCT03356678
Sponsor
Samsung Medical Center
Status
COMPLETED
Study type
OBSERVATIONAL
Relapsed or Refractory Peripheral T-cell Lymphoma
Start date
2016-09-23
Primary completion
2017-06-30
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.